FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:293-297 January 20, 2005 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The Food and Drug Administration (FDA) is responsible for the safety and efficacy of most food products and all human and veterinary drugs, biologic products, medical devices, cosmetics, and products emitting radiation that are sold within U.S. borders — a list that accounts for an estimated 20 percent of consumer spending, valued at approximately $1.5 trillion.^1,2 Although the FDA is often at the center of controversy, the agency has consistently commanded the respect of more than two thirds of American adults.³ Given the magnitude of the FDA's responsibility and the scope of its public trust, I will examine the performance . . . [Full Text of this Article]

The Need for Equipoise

Post-Marketing Surveillance

Communication of Information about Risks of Drugs and Devices

Controlling the Cost of Drugs

This article has been cited by other articles:

• Ray, W. A., Stein, C. M. (2006). Reform of Drug Regulation -- Beyond an Independent Drug-Safety Board. NEJM 354: 194-201 [Full Text]  
• Schwartz, D. J., Dalen, J. E., Ridker, P. M., Buring, J. E. (2005). Aspirin in the prevention of cardiovascular disease in women.. NEJM 352: 2751-2752 [Full Text]